FDA Reviewers: Nasacort Allergy Spray Can Go OTC

The treatment has a 'favorable risk-benefit profile'

   

FDA Reviewers: Nasacort Allergy Spray Can Go OTC

11927463 prescription medicine spilling from open bottles 300x142 FDA Reviewers: Nasacort Allergy Spray Can Go OTCAn allergy drug from Sanofi (SNY) could soon be sold without a prescription.

Reviewers with the U.S. Food and Drug Administration (FDA) have found that Nasacort AQ, which is used to mitigate the symptoms of allergies and hay fever, is safe enough to be sold over the counter. The treatment currently requires a prescription, Reuters notes.

pills 200x200 FDA Reviewers: Nasacort Allergy Spray Can Go OTC
FDA Says No to Merck Insomnia Drug

On Wednesday, an FDA advisory committee will consider issuing a recommendation to regulators to allow over-the-counter sales of the drug. The reviewers’ opinion

According to an opinion published online, the reviewers said that Nasacort had “a favorable risk-benefit profile.”

In May, dupilumab, and anti-asthma drug developed by Sanofi and Regeneron Pharmaceuticals (REGN), reportedly reduced asthma attacks by 87% in a 12-week, 104-patient study.

Shares of Sanofi climbed more than 1% in Tuesday morning trading.


Article printed from InvestorPlace Media, http://investorplace.com/2013/07/fda-reviewers-nasacort-allergy-spray-can-go-otc/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.